JMJulia Eisenhardt de Mello

Julia Eisenhardt de Mello

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Eisenhardt de Mello has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Occupational exposure to isoflurane impairs liver redox status in mice

    by Marina Zanin, Antonio Sergio Varela Junior, Julia Eisenhardt de Mello, Rosélia Maria Spanevello, Martielo Ivan Gehrcke, Maria Eduarda Bicca Dode, Mariana Gobbo Braz, Carine Dahl Corcini

    Introdução: O isoflurano, amplamente utilizado em ambientes médicos e científicos, desempenha um papel significativo na geração de gases anestésicos residuais. A exposição ocupacional a este anestésico pode resultar em graves prejuízos à saúde devido à exposição crônica, principalmente no que diz respeito ao impacto oxidativo. O fígado, sendo o principal órgão responsável pelo metabolismo deste anestésico, é um alvo chave para estes efeitos adversos. Objetivo: Avaliar os efeitos da exposição ocupacional crônica ao isoflurano sobre o estado redox hepático de camundongos e investigar se a interrupção da exposição pode restaurar o equilíbrio oxidativo. Métodos: Os ratos foram expostos a 50 ppm de isoflurano durante 5 horas por dia durante um período de 30 dias. Após a exposição, eles foram sacrificados no primeiro dia após o término da exposição (G2) ou 20 dias após a última exposição (G3) e comparados ao grupo controle (G1). Suas amostras de tecido hepático foram submetidas a análises bioquímicas, avaliando-se a concentração de espécies reativas de oxigênio e substâncias reativas ao ácido tiobarbitúrico, bem como a atividade das enzimas catalase e superóxido dismutase. Resultados: A exposição ocupacional ao isoflurano pode afetar a atividade de enzimas antioxidantes no tecido hepático. Os indivíduos expostos apresentaram redução da atividade da catalase, associada a um aumento tardio e não fisiológico da atividade da superóxido dismutase. Conclusão: O isoflurano em concentrações supostamente seguras perturba o estado redox hepático dos indivíduos expostos, e a interrupção da exposição não garante o retorno ao equilíbrio oxidativo.

  • Protective Effects of Eugenia uniflora Red Fruit on Brain in a Rat Model of Type 2 Diabetes: Mechanistic Insights

    by Imtiaz Ahmad, Juliane de Souza Cardoso, Julia Eisenhardt de Mello, Fernanda Cardoso Teixeira, Juliane Torchelsen Saraiva, Natália Pontes Bona, Marcia Vizzotto, Lucas Petitemberte de Souza, William Borges Domingues, Vinicius Farias Campos, et al.

    The current study aimed to evaluate the in-vitro toxicity and in-vivo antidiabetic effects of a standardized extract from Eugenia uniflora (E. uniflora) fruit, comparing its efficacy to metformin (Met), a widely used anti-hyperglycemic drug. First, toxicity of the extract was determined by MTT assay in 3T3 cell line and primary astrocyte culture. Then Wistar rats were divided into four groups: I- Control, II- type 2 diabetes mellitus (T2DM), III- T2DM + Met and IV- T2DM + E. uniflora. To induce T2DM, groups II, III and IV received a high fat diet (HFD) for 3 weeks followed by a single intraperitoneal (i.p.) dose of streptozotocin (STZ, 35 mg/kg). Animals of group I received normal diet and vehicle (i.p.). Group III received Met (250 mg/kg) and group IV received E. uniflora (200 mg/kg) intragastric pathway, once a day, throughout all experimental protocol. Animals from the groups I and II received water in the same volume. Results showed that cell viability was not affected. In-vivo, E. uniflora and Met prevented the change in serum levels of glucose, cholesterol, LDL, triglyceride and interleukin-6. Furthermore, extract and Met improved oxidative stress markers and antioxidant enzyme activity in the brain (cerebral cortex, hippocampus, striatum). Furthermore, extract enhanced the downstream insulin signaling pathway, including insulin receptor substrate 1, forkhead box protein O-3a, as well as activated the nuclear factor erythroid 2-related factor 2 in the cerebral cortex. This study indicates that E. uniflora extract may have potential in preventing complications associated with T2DM; nevertheless, additional studies are required to confirm these effects and establish their clinical significance. Graphical Abstract


  • 3-(3-(diethylamino)propyl)-2-(4-(methylthio)phenyl)thiazolidin-4-one Attenuates Scopolamine-induced Cognitive Impairment in Rats: Insights Into Neuroprotective Effects

    by Anita Avila de Souza, Kelen Cristiane Machado Goularte, Raphaela Cassol Piccoli, Solange Vega Custódio, Julia Eisenhardt de Mello, Melinda Gomes Victor, William Borges Domingues, Lucas Petitemberte de Souza, Laís dos Santos Gonçalves, Vinicius Farias Campos, et al.

    Alzheimer’s Disease (AD) is characterized by memory decline, dysregulation in cholinergic and purinergic signaling, neuroinflammation, and oxidative stress. Current treatments are limited, highlighting the need for new compounds to prevent or delay AD progression. Thiazolidinones have emerged as promising candidates due to their antioxidant, anti-inflammatory, and anticholinesterase properties. The aim of this study was to evaluate the effects of 3-(3-(diethylamino)propyl)-2-(4-(methylthio)phenyl)thiazolidin-4-one (DS27) in a rat model of scopolamine-induced memory deficits. Male rats were divided into groups: I - Control, II - Scopolamine (SCO) (1 mg/kg), III - SCO and DS27 (5 mg/kg), IV - SCO and DS27 (10 mg/kg), V - SCO and donepezil (5 mg/kg). The animals were treated orally with DS27 or donepezil for seven days. On the 8th day, they underwent the open field test and inhibitory avoidance training, followed by intraperitoneal administration SCO. Twenty-four hours later, an inhibitory avoidance test was conducted. Acetylcholinesterase (AChE) activity, oxidative stress, and inflammatory and purinergic parameters were analyzed in the cerebral cortex, hippocampus, cerebrospinal fluid, serum, lymphocytes, and liver. DS27 prevented memory deficits, alterations in AChE activity, and oxidative damage induced by SCO in brain structures. Additionally, DS27 prevented SCO-induced decrease in IL-10 levels, and increase in IL-6, and TNF-α expression in the cerebral cortex, and normalized ATP and ADP hydrolysis in cerebrospinal fluid and lymphocytes. DS27 did not induce oxidative stress in the liver or alter serum biochemical parameters. These findings suggest that DS27 has significant neuroprotective properties and could be a promising alternative for treating neurodegenerative diseases like AD. Graphical Abstract


  • Treatment with Blackberry Extract and Metformin in Sporadic Alzheimer’s Disease Model: Impact on Memory, Inflammation, Redox Status, Phosphorylated Tau Protein and Insulin Signaling

    by Julia Eisenhardt de Mello, Fernanda Cardoso Teixeira, Alessandra dos Santos, Karina Luduvico, Mayara Sandrielly Soares de Aguiar, William Borges Domingues, Vinicius Farias Campos, Rejane Giacomelli Tavares, Augusto Schneider, Francieli Moro Stefanello, et al.

    Natural products offer promising potential for the development of new therapies for Alzheimer's disease (AD). Blackberry fruits are rich in phytochemical compounds capable of modulating pathways involved in neuroprotection. Additionally, drug repurposing and repositioning could also accelerate the development of news treatments for AD. In light of the reduced brain glucose metabolism in AD, an alternative approach has been the use of the drug metformin. Thus, the aim of this study was to evaluate the effect of treatment with blackberry extract in a model of AD induced by streptozotocin (STZ) and compare it with metformin treatment. Male rats were divided into groups: I - Control; II - STZ; III - STZ + blackberry extract (100 mg/kg); IV - STZ + blackberry extract (200 mg/kg) and V - STZ + metformin (150 mg/kg). The animals received intracerebroventricular injection of STZ or buffer. Seven days after the surgical procedure, the animals were treated orally with blackberry extract or metformin for 21 days. Blackberry extract and metformin prevented the memory impairment induced by STZ. In animals of group II, an increase in acetylcholinesterase activity, phosphorylated tau protein, IL-6, oxidative damage, and gene expression of GSK-3β and Nrf2 was observed in the hippocampus. STZ induced a decrease in IL-10 levels and down-regulated the gene expression of Akt1, IRS-1 and FOXO3a. Blackberry extract and metformin prevented the alterations in acetylcholinesterase activity, IL-6, GSK3β, Nrf2, and oxidative damage. In conclusion, blackberry extract exhibits multi-target actions in a model of AD, suggesting new therapeutic potentials for this neurodegenerative disease. Graphical Abstract